The UAE’s Big Bet on Genomic Medicine with Mohamed Alameri and Albarah El-Khani

The UAE’s Big Bet on Genomic Medicine with Mohamed Alameri and Albarah El-Khani

June 23, 2026 · 46 min

About this episode

The episode discusses the Emirati Genome Program and its impact on genomic medicine in the UAE.

The future of genomics has arrived in Abu Dhabi. On today’s show, Dr. Mohamed Alameri of the UAE Department of Health and Albarah El-Khani of M42 describe one of the most ambitious precision medicine efforts underway anywhere in the world: the Emirati Genome Program, which has already sequenced more than 900,000 genomes and is rapidly integrating that data into everyday healthcare. The UAE program is not only a large sequencing effort and database—soon to be made available for research anywhere—but a coordinated national strategy built on prevention, diagnosis, and long-term population health. Particularly striking is the UAE’s focus on inherited and autosomal recessive diseases, which occur at significantly higher prevalence in the region than in many Western populations. Rather than treating genomics as an isolated research exercise, the program has pushed aggressively into premarital screening, newborn genomic screening, pharmacogenomics, hereditary cancer risk assessment, and rare disease diagnosis. “We truly believe in the philosophy of ‘sequence once, analyze for life,’” says El-Khani. “Imagine a society where every individual from birth holds a whole genome sequence…

People in this episode

Host: Theral Timpson

Guests: Mohamed Alameri, Albarah El-Khani

Topics covered

Mentioned in this episode

Organizations: UAE Department of Health, M42

Places: UAE, Abu Dhabi

More episodes of Mendelspod Podcast

Explore listener stats, chart rankings, contacts and more on the Mendelspod Podcast podcast page.